BCLI
BRAINSTORM CELL THERAPUTC
BCLI
BCLI
Delisted
BCLI was delisted on the 17th of July, 2025.
37 hedge funds and large institutions have $7.61M invested in BRAINSTORM CELL THERAPUTC in 2019 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 11 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
100% less call options, than puts
Call options by funds: $7K | Put options by funds: $2.12M
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
37
Holding in Top 10
–
Calls
$7K
Puts
$2.12M
Top Buyers
| 1 | +$254K | |
| 2 | +$159K | |
| 3 | +$128K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$123K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$106K |
Top Sellers
| 1 | -$2.32M | |
| 2 | -$240K | |
| 3 | -$197K | |
| 4 |
EMG
ETF Managers Group
Summit,
New Jersey
|
-$88.6K |
| 5 |
DG
Delek Group
Herzliya,
Israel
|
-$24.9K |